ROLLY's active compound is 5MAPB, short for 5-(2-methylaminopropyl)benzofuran. It is federally unscheduled, attorney reviewed, and sits outside the controlled substances framework.

5MAPB works primarily as a serotonin releasing agent, with a dopamine to serotonin release ratio of roughly 1 to 6 or greater. That serotonin dominant profile is what gives ROLLY its warm, connective character rather than a stimulant edge. It is built for connection and mood elevation, not a jittery energy spike.

Onset: 45 to 90 minutes after taking. Peak: 2 to 3 hours in. Duration: 6 to 8 hours total. Afterglow: Positive and clean, no crash the next day.

• Elevated mood without an anxious or jittery edge.
• A genuine sense of connection: socially open, present, easy to talk to people.
• Smooth and controlled throughout, clear headed rather than foggy or disoriented.
• A comedown that fades gently instead of dropping off a cliff.

Built for festival, dance, and community environments. People describe it as lowering the walls that usually keep them guarded, making it easier to relate authentically to the people around them. It is for anyone who wants deeper connection, whether that is with themselves or with the people they are spending time with, without relying on alcohol or settling for a product that only takes the edge off.

Each ROLLY tablet is scored to split into two doses, so a single sachet covers a gentle introduction or a full experience.

• One tablet. A lighter entry dose, recommended for first time users or anyone wanting a gentler introduction.
• Two tablets. The full dose, for users who want the complete ROLLY experience. Experienced users typically go straight here.

Adult use only, 21 and older. New users are encouraged to start with one.

Each tablet is 570mg total per tablet, with 54.729mg of 5MAPB per tablet (96.017 mg per gram), roughly 9.6% of tablet weight. The remaining weight is inert filler, standard practice for a low dose tablet press. This is how any low milligram active compound gets pressed into a stable, consistently dosed tablet, not a red flag.

Every tablet is lab tested by Tryptomics, a DEA-registered lab based in Longmont, Colorado. The Certificate of Analysis screens for a full panel of synthetic tryptamine analytes. Every compound outside 5MAPB itself comes back not detected (ND). The COA exists to confirm what is not in the product as much as what is.

See the certificate of analysis →

• Adult use only, 21+.
• Shelf stable, no special storage requirements.
• ROLLY carries the same SSRI interaction caution as other serotonin active botanicals, such as kratom. Anyone currently taking an SSRI or other serotonergic medication should not combine it with ROLLY and should talk to a doctor about any planned use.
• As with any psychoactive product, do not combine with alcohol or other substances without understanding the interaction risk, and do not drive or operate machinery while under the effects.

Data on the compound's effects and safety profile comes from in vitro research, preclinical studies, and self-reported use data such as Erowid and PsychonautWiki. Human clinical trial data is limited, so this is what is currently known rather than exhaustive medical clearance.

5MAPB is federally unscheduled, attorney reviewed, and outside the controlled substances framework.

Legal status can vary by state and locality. Confirm the rules in your specific area, since state and local regulations can differ.

Shelf stable. No refrigeration or special storage needed. Store as you would any supplement: cool and dry, out of direct sunlight.